Lyka Labs Ltd.
BSE: 500259 | Sector: Health care |
NSE: LYKALABS | ISIN Code: INE933A01014 |
BSE 11:53 | 24 May | 130.40 |
-3.00 (-2.25%) |
OPEN
131.40 |
HIGH
134.35 |
LOW
129.30 |
NSE 11:38 | 24 May | 129.95 |
-3.50 (-2.62%) |
OPEN
131.00 |
HIGH
134.35 |
LOW
128.90 |
OPEN | 131.40 |
PREVIOUS CLOSE | 133.40 |
VOLUME | 4069 |
52-Week high | 267.20 |
52-Week low | 50.70 |
P/E | 8.70 |
Mkt Cap.(Rs cr) | 374 |
Buy Price | 129.45 |
Buy Qty | 7.00 |
Sell Price | 130.40 |
Sell Qty | 102.00 |
Lyka Labs Ltd. (LYKALABS) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Aurobindo Pharma | 543.40 | -15.45 | -2.76 | 3112.91 |
Cipla | 973.60 | 3.05 | 0.31 | 2468.28 |
Dr Reddy's Labs | 4343.05 | 68.80 | 1.61 | 2186.40 |
Sun Pharma.Inds. | 921.20 | -0.25 | -0.03 | 2139.70 |
Divi's Lab. | 3707.00 | -190.55 | -4.89 | 1954.72 |
Alkem Lab | 2954.50 | -30.55 | -1.02 | 1685.08 |
Glenmark Pharma. | 396.25 | -7.15 | -1.77 | 1649.45 |
Zydus Lifesci. | 365.50 | 3.10 | 0.86 | 1476.20 |
Lupin | 612.55 | -5.85 | -0.95 | 1258.62 |
Alembic Pharma | 772.60 | 12.20 | 1.60 | 1175.39 |
Ipca Labs. | 959.10 | -17.95 | -1.84 | 1140.77 |
Torrent Pharma. | 2601.50 | -14.60 | -0.56 | 1137.85 |
Gland Pharma | 2908.35 | -72.60 | -2.44 | 997.01 |
Laurus Labs | 566.00 | -6.55 | -1.14 | 956.11 |
Sanofi India | 6620.00 | -16.45 | -0.25 | 944.40 |
Abbott India | 17658.15 | -94.35 | -0.53 | 690.69 |
Ajanta Pharma | 1701.35 | -24.75 | -1.43 | 675.64 |
Wockhardt | 290.85 | 9.35 | 3.32 | 593.29 |
Granules India | 283.15 | 3.00 | 1.07 | 552.78 |
Pfizer | 4299.70 | -107.65 | -2.44 | 497.61 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices